{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:13:07Z","timestamp":1789999987049,"version":"4.0.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,8,29]],"date-time":"2009-08-29T00:00:00Z","timestamp":1251504000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1007\/s12185-009-0411-5","type":"journal-article","created":{"date-parts":[[2009,8,28]],"date-time":"2009-08-28T13:02:53Z","timestamp":1251464573000},"page":"522-525","source":"Crossref","is-referenced-by-count":14,"title":["Cytogenetic abnormalities in essential thrombocythemia at presentation and transformation"],"prefix":"10.1007","volume":"90","author":[{"given":"Matjaz","family":"Sever","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagop","family":"Kantarjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry","family":"Pierce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeev","family":"Estrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srdan","family":"Verstovsek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,8,29]]},"reference":[{"issue":"4","key":"411_CR1","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1182\/blood-2007-04-083501","volume":"110","author":"A Tefferi","year":"2007","unstructured":"Tefferi A, Thiele J, Orazi A, Kvasnicka HM, Barbui T, Hanson CA, et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood. 2007;110(4):1092\u20137.","journal-title":"Blood"},{"issue":"22","key":"411_CR2","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1001\/archinte.165.22.2651","volume":"165","author":"CS Chim","year":"2005","unstructured":"Chim CS, Kwong YL, Lie AK, Ma SK, Chan CC, Wong LG, et al. Long-term outcome of 231 patients with essential thrombocythemia: prognostic factors for thrombosis, bleeding, myelofibrosis, and leukemia. Arch Intern Med. 2005;165(22):2651\u20138.","journal-title":"Arch Intern Med"},{"issue":"2","key":"411_CR3","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/sj.leu.2404500","volume":"21","author":"N Gangat","year":"2007","unstructured":"Gangat N, Wolanskyj AP, McClure RF, Li CY, Schwager S, Wu W, et al. Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients. Leukemia. 2007;21(2):270\u20136.","journal-title":"Leukemia"},{"issue":"11","key":"411_CR4","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.3324\/haematol.13346","volume":"93","author":"F Passamonti","year":"2008","unstructured":"Passamonti F, Rumi E, Arcaini L, Boveri E, Elena C, Pietra D, et al. Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients. Haematologica. 2008;93(11):1645\u201351.","journal-title":"Haematologica"},{"issue":"5","key":"411_CR5","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/j.1600-0609.2008.01038.x","volume":"80","author":"A Tefferi","year":"2008","unstructured":"Tefferi A, Gangat N, Wolanskyj AP, Schwager S, Pardanani A, Lasho TL, et al. 20+ yr without leukemic or fibrotic transformation in essential thrombocythemia or polycythemia vera: predictors at diagnosis. Eur J Haematol. 2008;80(5):386\u201390.","journal-title":"Eur J Haematol"},{"issue":"2","key":"411_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4065\/81.2.159","volume":"81","author":"AP Wolanskyj","year":"2006","unstructured":"Wolanskyj AP, Schwager SM, McClure RF, Larson DR, Tefferi A. Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors. Mayo Clin Proc. 2006;81(2):159\u201366.","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"411_CR7","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1600-0609.2006.00688.x","volume":"77","author":"PG Heller","year":"2006","unstructured":"Heller PG, Lev PR, Salim JP, Kornblihtt LI, Goette NP, Chazarreta CD, et al. JAK2V617F mutation in platelets from essential thrombocythemia patients: correlation with clinical features and analysis of STAT5 phosphorylation status. Eur J Haematol. 2006;77(3):210\u20136.","journal-title":"Eur J Haematol"},{"issue":"5","key":"411_CR8","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/sj.leu.2404604","volume":"21","author":"K Ohyashiki","year":"2007","unstructured":"Ohyashiki K, Aota Y, Akahane D, Gotoh A, Ohyashiki JH. JAK2(V617F) mutational status as determined by semiquantitative sequence-specific primer-single molecule fluorescence detection assay is linked to clinical features in chronic myeloproliferative disorders. Leukemia. 2007;21(5):1097\u20139.","journal-title":"Leukemia"},{"issue":"2","key":"411_CR9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1532\/IJH97.E0607","volume":"86","author":"Z Rudzki","year":"2007","unstructured":"Rudzki Z, Sacha T, Stoj A, Czekalska S, Wojcik M, Skotnicki AB, et al. The gain-of-function JAK2 V617F mutation shifts the phenotype of essential thrombocythemia and chronic idiopathic myelofibrosis to more \u201cerythremic\u201d and less \u201cthrombocythemic\u201d: a molecular, histologic, and clinical study. Int J Hematol. 2007;86(2):130\u20136.","journal-title":"Int J Hematol"},{"issue":"8","key":"411_CR10","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.leukres.2006.09.005","volume":"31","author":"M Speletas","year":"2007","unstructured":"Speletas M, Katodritou E, Daiou C, Mandala E, Papadakis E, Kioumi A, et al. Correlations of JAK2-V617F mutation with clinical and laboratory findings in patients with myeloproliferative disorders. Leuk Res. 2007;31(8):1053\u201362.","journal-title":"Leuk Res"},{"issue":"3","key":"411_CR11","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1182\/blood-2006-12-064287","volume":"110","author":"AM Vannucchi","year":"2007","unstructured":"Vannucchi AM, Antonioli E, Guglielmelli P, Rambaldi A, Barosi G, Marchioli R, et al. Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia. Blood. 2007;110(3):840\u20136.","journal-title":"Blood"},{"issue":"2","key":"411_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000064754","volume":"108","author":"DP Steensma","year":"2002","unstructured":"Steensma DP, Tefferi A. Cytogenetic and molecular genetic aspects of essential thrombocythemia. Acta Haematol. 2002;108(2):55\u201365.","journal-title":"Acta Haematol"},{"issue":"4","key":"411_CR13","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s00277-004-0977-1","volume":"84","author":"U Bacher","year":"2005","unstructured":"Bacher U, Haferlach T, Kern W, Hiddemann W, Schnittger S, Schoch C. Conventional cytogenetics of myeloproliferative diseases other than CML contribute valid information. Ann Hematol. 2005;84(4):250\u20137.","journal-title":"Ann Hematol"},{"issue":"1","key":"411_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1600-0609.2009.01246.x","volume":"83","author":"N Gangat","year":"2009","unstructured":"Gangat N, Tefferi A, Thanarajasingam G, Patnaik M, Schwager S, Ketterling R, et al. Cytogenetic abnormalities in essential thrombocythemia: prevalence and prognostic significance. Eur J Haematol. 2009;83(1):17\u201321.","journal-title":"Eur J Haematol"},{"issue":"11","key":"411_CR15","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.leukres.2005.03.011","volume":"29","author":"HH Hsiao","year":"2005","unstructured":"Hsiao HH, Ito Y, Sashida G, Ohyashiki JH, Ohyashiki K. De novo appearance of der(1;7)(q10;p10) is associated with leukemic transformation and unfavorable prognosis in essential thrombocythemia. Leuk Res. 2005;29(11):1247\u201352.","journal-title":"Leuk Res"},{"issue":"3","key":"411_CR16","first-page":"381","volume":"20","author":"AD Panani","year":"2006","unstructured":"Panani AD. Cytogenetic findings in untreated patients with essential thrombocythemia. In Vivo. 2006;20(3):381\u20134.","journal-title":"In Vivo"},{"issue":"5","key":"411_CR17","first-page":"867","volume":"21","author":"AD Panani","year":"2007","unstructured":"Panani AD. Single chromosomal abnormalities in Philadelphia-negative chronic myeloproliferative disorders. In Vivo. 2007;21(5):867\u201370.","journal-title":"In Vivo"},{"issue":"1","key":"411_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0165-4608(89)90127-1","volume":"43","author":"M Sessarego","year":"1989","unstructured":"Sessarego M, Defferrari R, Dejana AM, Rebuttato AM, Fugazza G, Salvidio E, et al. Cytogenetic analysis in essential thrombocythemia at diagnosis and at transformation. A 12-year study. Cancer Genet Cytogenet. 1989;43(1):57\u201365.","journal-title":"Cancer Genet Cytogenet"},{"issue":"7","key":"411_CR19","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","volume":"100","author":"JW Vardiman","year":"2002","unstructured":"Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002;100(7):2292\u2013302.","journal-title":"Blood"},{"issue":"1","key":"411_CR20","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/sj.leu.2404007","volume":"20","author":"R McClure","year":"2006","unstructured":"McClure R, Mai M, Lasho T. Validation of two clinically useful assays for evaluation of JAK2 V617F mutation in chronic myeloproliferative disorders. Leukemia. 2006;20(1):168\u201371.","journal-title":"Leukemia"},{"issue":"3","key":"411_CR21","first-page":"517","volume":"9","author":"T Koike","year":"1995","unstructured":"Koike T, Uesugi Y, Toba K, Narita M, Fuse I, Takahashi M, et al. 5q-syndrome presenting as essential thrombocythemia: myelodysplastic syndrome or chronic myeloproliferative disorders? Leukemia. 1995;9(3):517\u20138.","journal-title":"Leukemia"},{"issue":"1","key":"411_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0165-4608(92)90376-J","volume":"61","author":"MD Reis","year":"1992","unstructured":"Reis MD, Sher GD, Lakhani A, Dube ID, Senn JS, Pinkerton PH. Deletion of the long arm of chromosome 5 in essential thrombocythemia. Cancer Genet Cytogenet. 1992;61(1):93\u20135.","journal-title":"Cancer Genet Cytogenet"},{"issue":"2","key":"411_CR23","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/(SICI)1096-8652(200006)64:2<120::AID-AJH9>3.0.CO;2-M","volume":"64","author":"H Takahashi","year":"2000","unstructured":"Takahashi H, Furukawa T, Hashimoto S, Kanazawa N, Satoh N, Suzuki N, et al. 5q\u2212 syndrome presenting chronic myeloproliferative disorders-like manifestation: a case report. Am J Hematol. 2000;64(2):120\u20133.","journal-title":"Am J Hematol"},{"issue":"2","key":"411_CR24","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/0165-4608(93)90172-I","volume":"67","author":"J Welborn","year":"1993","unstructured":"Welborn J. 5q\u2013 in essential thrombocythemia. Cancer Genet Cytogenet. 1993;67(2):150.","journal-title":"Cancer Genet Cytogenet"},{"issue":"5","key":"411_CR25","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/sj.leu.2404619","volume":"21","author":"M Sanada","year":"2007","unstructured":"Sanada M, Uike N, Ohyashiki K, Ozawa K, Lili W, Hangaishi A, et al. Unbalanced translocation der(1;7)(q10;p10) defines a unique clinicopathological subgroup of myeloid neoplasms. Leukemia. 2007;21(5):992\u20137.","journal-title":"Leukemia"},{"issue":"1","key":"411_CR26","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cancergencyto.2004.12.002","volume":"160","author":"JL Betz","year":"2005","unstructured":"Betz JL, Behairy AS, Rabionet P, Tirtorahardjo B, Moore MW, Cotter PD. Acquired inv(9): what is its significance? Cancer Genet Cytogenet. 2005;160(1):76\u20138.","journal-title":"Cancer Genet Cytogenet"},{"issue":"1","key":"411_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/BF03195656","volume":"50","author":"AM Udayakumar","year":"2009","unstructured":"Udayakumar AM, Pathare AV, Dennison D, Raeburn JA. Acquired pericentric inversion of chromosome 9 in acute myeloid leukemia. J Appl Genet. 2009;50(1):73\u20136.","journal-title":"J Appl Genet"},{"issue":"6","key":"411_CR28","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s004390050041","volume":"106","author":"TS Wan","year":"2000","unstructured":"Wan TS, Ma SK, Chan LC. Acquired pericentric inversion of chromosome 9 in essential thrombocythemia. Hum Genet. 2000;106(6):669\u201370.","journal-title":"Hum Genet"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-009-0411-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-009-0411-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-009-0411-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-009-0411-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T05:01:28Z","timestamp":1559451688000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-009-0411-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,29]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["411"],"URL":"https:\/\/doi.org\/10.1007\/s12185-009-0411-5","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,29]]}}}